United States Hyaluronic Acid Viscosupplementation Market 2011-2021

Jul 21, 2015, 12:13 ET from Research and Markets

DUBLIN, July 15, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/7lqjjc/us_market_for) has announced the addition of the "US Market for Hyaluronic Acid Viscosupplementation 2011-2021" report to their offering.

Viscosupplementation products are approved for direct injection into the knee to relieve pain caused by osteoarthritis. Though the active mechanism is not completely understood, the intention is to restore the shock absorbing nature of the joint fluid.

Although these products treat the symptoms of osteoarthritis and are not permanent cures, patients generally report decreased pain and an improvement in performance of daily activities. Despite the method of application, these products are classified as medical devices and not pharmaceuticals, although some claim that there are associated anti-inflammatory effects.

There are three forms of hyaluronic acid products available on the market: single-injection, three-injection and five-injection cycles. These products vary in their volumes and concentrations of sodium hyaluronate.

The three-injection and five-injection products are well-established in the U.S. market. The first single-injection product was approved by the FDA in February 2009; the corresponding market has grown very rapidly.

Key Topics Covered:

1.Research Methodology

2. Orthopedic Hyaluronic Acid Viscosupplementation Market

2.1 Introduction

2.1.1 Benefits Of Viscosupplementation

2.1.2 Synovial Fluid

2.1.3 Product Types Single-Injection Products Three-Injection Cycle Products Three/Five-Injection Cycle Products

2.1.4 Reimbursement

2.2 Market Overview

2.3 Market Analysis And Forecast

2.3.1 Total Hyaluronic Acid Viscosupplementation Market

2.3.2 Single-Injection Hyaluronic Acid Viscosupplementation Market

2.3.3 Three-Injection Hyaluronic Acid Viscosupplementation Market

2.3.4 Five-Injection Hyaluronic Acid Viscosupplementation Market

2.4 Drivers And Limiters

2.4.1 Market Drivers

2.4.2 Market Limiters

2.5 Competitive Analysis

Companies Mentioned

- Anika Therapeutics

- Bioventus

- Ferring Pharmaceuticals

- Fidia Pharmaceuticals

- Genzyme

- Zimmer

For more information visit http://www.researchandmarkets.com/research/7lqjjc/us_market_for

Media Contact:

Laura Wood, +353-1-481-1716, press@researchandmarkets.net


SOURCE Research and Markets